🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a dose-ranging study designed to investigate the efficacy and safet...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-12
Trial ID
NCT01490632
Treatments Being Tested
Evaluate the safety and tolerability of VX-659 in healthy subjects...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT03029455
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
To investigate safety, tolerability, pharmacokinetics, pharmacodynamics and...
Status
Completed
Location
Fukuoka Clinical Site
Start Date
2019-09-12
Trial ID
NCT04079062
Treatments Being Tested
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
This is a Phase I Randomised Single-blind Placebo-controlled Study to Asses...
Status
Completed
Location
Research Site
Start Date
2023-05-02
Trial ID
NCT05848440
The purpose of this study is to evaluate the efficacy of Bermekimab, compar...
Status
Terminated
Location
Dawes Fretzin Clinical Research Group
Start Date
2021-09-02
Trial ID
NCT04990440
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of linsitinib ...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2011-12
Trial ID
NCT01465815
This study is an open label study followed by a randomised, double-blind, p...
Status
Unknown
Location
Centre Georges Grancois Leclerc
Start Date
2022-03-15
Trial ID
NCT05240131
Treatments Being Tested
This study will assess the safety, tolerability, pharmacokinetics (PK), and...
Status
Completed
Location
Research Site
Start Date
2022-05-18
Trial ID
NCT05384262